Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Early Phase 1
1(33.3%)
3Total
N/A(2)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02499601Not ApplicableUnknown

CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD)

Role: lead

NCT01956526Not ApplicableUnknown

CORolla™ TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction

Role: lead

NCT01347125Early Phase 1Terminated

ImCardia for DHF to Treat Diastolic Heart Failure (DHF) Patient a Pilot Study

Role: lead

All 3 trials loaded